Medicine
Efavirenz 50 mg capsule
Efavirenz 50 mg capsule is a generic prescription medicine for oral use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Efavirenz capsules should be stored at 20° to 25°C (68° to 77°F), excursions…
Key facts
- Active ingredient (INN)
- Efavirenz
- Brand
- Sold under the generic name
- Strength
- 50 mg
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 3 blister pack, 30 capsules
- Manufacturer
- Aurobindo PharmaIndia
- Origin register
- US FDA, United States
- Storage
- Efavirenz capsules should be stored at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J05AG03 Efavirenz
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 15 December 2017
- Identifiers
- RxCUI 205290, 205291, 205292DailyMed set ID 4c57ad7f-321a-46c8-851a-c895466eb8e1NDC 65862-104Application ANDA078064
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 3 blister pack in 1 carton / 10 capsule in 1 blister pack | 65862-104-10 | Aurobindo PharmaIndia | 15 December 2017 |
| 30 capsule in 1 bottle | 65862-104-30 | Aurobindo PharmaIndia | 15 December 2017 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Efavirenz
Clinical summary
Efavirenz is a human immunodeficiency virus 1 non-nucleoside analog reverse transcriptase inhibitor indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults, among other approved uses. MedsAcross supplies Efavirenz for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about EfavirenzFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Efavirenz prescribing information (Macleods Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Efavirenz Teva: European public assessment report (EPAR) · European Medicines Agency
Need Efavirenz 50 mg capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.